Thalmann Healthcare News Today : Breaking News, Live Updates & Top Stories | Vimarsana

DGAP-News: Immunic, Inc to Participate in Investor Conferences in September

Issuer: Immunic, Inc. / Key word(s): Conference Immunic, Inc. to Participate in Investor Conferences in September 01.09.2022 / 12:30 CET/CEST The issuer is solely responsible for

United statesEdna kaplanPaula schwartzJessica breuDaniel vittExchange commissionRx communications groupWells fargoImmunic incDistribution servicesInvestor conferencesAnnual biopharma conference daniel vittChief executive officerInvestor relationsAnnual biopharma conferenceThalmann healthcare

Immunic, Inc to Participate in Investor Conferences in September

/PRNewswire/ Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused.

United statesEdna kaplanPaula schwartzJessica breuDaniel vittExchange commissionRx communications groupWells fargoImmunic incAnnual biopharmaChief executive officerInvestor relationsAnnual biopharma conferenceThalmann healthcareThalmann healthcare conferenceNew york

Salarius Pharmaceuticals to Present at the Virtual Ladenburg Thalmann Healthcare Conference

Salarius Pharmaceuticals to Present at the Virtual Ladenburg Thalmann Healthcare Conference
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

United statesDavid arthurJohanna bennettMaureen mcenroeTiberend strategic advisors incNational pediatric cancer foundationSalarius pharmaceuticalsDrug administrationSalarius pharmaceuticals incProduct development awardResearch institute of texasChief executive officerThalmann healthcare conferenceThalmann healthcareFast track designationOrphan drug designation